These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35961853)

  • 1. Impact of an outpatient parenteral antimicrobial treatment (OPAT) as part of a paediatric-specific PROA program.
    Fernández-Polo A; Ramon-Cortes S; Plaja-Dorca J; Bartolomé-Comas R; Vidal-Valdivia L; Soler-Palacín P;
    Enferm Infecc Microbiol Clin (Engl Ed); 2023 Apr; 41(4):230-234. PubMed ID: 35961853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient parenteral antimicrobial therapy with continuous infusion of meropenem: A retrospective analysis of three years of clinical experience.
    Dubois-Silva Á; Otero-Plaza L; Dopico-Santamariña L; Mozo-Ríos A; Hermida-Porto L; Feal-Cortizas B; García-Queiruga M; Pértega-Díaz S; Lamelo-Alfonsín F; Vidán-Martínez L
    Enferm Infecc Microbiol Clin (Engl Ed); 2023; 41(6):321-328. PubMed ID: 36610829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases.
    Conant MM; Erdman SM; Osterholzer D
    J Antimicrob Chemother; 2014 Jun; 69(6):1695-700. PubMed ID: 24532684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial stewardship in the outpatient parenteral antimicrobial therapy (OPAT) setting: the impact of prescription assessment by an infectious diseases specialist.
    Cassettari V; Novato N; Onuchic MHF
    Braz J Infect Dis; 2021; 25(2):101560. PubMed ID: 33716018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximising the opportunity of a self-administration outpatient parenteral antimicrobial therapy pathway.
    Bodycot J; Mashonganyika L; Kucziw N; Ingham C; Bhukera S; White HA
    Br J Nurs; 2021 Jan; 30(2):S4-S10. PubMed ID: 33529119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and cost-effectivity analysis of outpatient parenteral antimicrobial therapy unit in infectious disease clinical practices: Turkey perspective.
    Bastug A; Oksuz E; Kazancioglu S; Malhan S; Ozbay BO; Bodur H
    Int J Clin Pract; 2021 Jun; 75(6):e14147. PubMed ID: 33709495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of the first comprehensive outpatient parenteral antimicrobial therapy program in a tertiary care hospital in Japan.
    Hase R; Yokoyama Y; Suzuki H; Uno S; Mikawa T; Suzuki D; Muranaka K; Hosokawa N
    Int J Infect Dis; 2020 Jun; 95():210-215. PubMed ID: 32205285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient parenteral antibiotic therapy (OPAT) through elastomeric continuous infusion pumps in a real-life observational study: Characteristics, safety, and efficacy analysis.
    Giuliano G; Tarantino D; Tamburrini E; Nurchis MC; Scoppettuolo G; Raffaelli F
    Enferm Infecc Microbiol Clin (Engl Ed); 2024 Jun; ():. PubMed ID: 38902156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The success rate and complications of midline catheters in pediatric outpatient parenteral antibiotic therapy (OPAT).
    Fläring U; Lundevall H; Norberg Å; Andersson A
    Eur J Pediatr; 2024 Apr; 183(4):1703-1709. PubMed ID: 38227054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain.
    González-Ramallo VJ; Mirón-Rubio M; Mujal A; Estrada O; Forné C; Aragón B; Rivera AJ
    Int J Antimicrob Agents; 2017 Jul; 50(1):114-118. PubMed ID: 28499957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of outcomes of outpatient parenteral antimicrobial therapy (OPAT) for necrotising otitis externa.
    Durojaiye OC; Slucka A; Kritsotakis EI
    Eur J Clin Microbiol Infect Dis; 2022 Jun; 41(6):941-949. PubMed ID: 35556187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.
    Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K
    Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of a disposable elastomeric continuous infusion pump for outpatient parenteral antimicrobial therapy (OPAT) in a UK setting.
    Durojaiye OC; Cole J; Kritsotakis EI
    J Chemother; 2024 Apr; 36(2):119-126. PubMed ID: 37942621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists.
    Gilchrist M; Seaton RA
    J Antimicrob Chemother; 2015 Apr; 70(4):965-70. PubMed ID: 25538169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years.
    Matthews PC; Conlon CP; Berendt AR; Kayley J; Jefferies L; Atkins BL; Byren I
    J Antimicrob Chemother; 2007 Aug; 60(2):356-62. PubMed ID: 17566002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient parenteral antimicrobial therapy: a report of three years experience.
    Glackin L; Flanagan F; Healy F; Slattery DM
    Ir Med J; 2014 Apr; 107(4):110-2. PubMed ID: 24834583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discharge Delays and Costs Associated With Outpatient Parenteral Antimicrobial Therapy for High-Priced Antibiotics.
    Bianchini ML; Kenney RM; Lentz R; Zervos M; Malhotra M; Davis SL
    Clin Infect Dis; 2020 Oct; 71(7):e88-e93. PubMed ID: 31665269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-administered outpatient parenteral antimicrobial therapy (S-OPAT) for infective endocarditis: a safe and effective model.
    Pajarón M; Fernández-Miera MF; Allende I; Arnaiz AM; Gutiérrez-Cuadra M; Cobo-Belaustegui M; Armiñanzas C; de Berrazueta JR; Fariñas MC; Sanroma P;
    Eur J Intern Med; 2015 Mar; 26(2):131-6. PubMed ID: 25596808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program.
    Quintens C; Steffens E; Jacobs K; Schuermans A; Van Eldere J; Lagrou K; De Munter P; Derdelinckx I; Peetermans WE; Spriet I
    Infection; 2020 Jun; 48(3):357-366. PubMed ID: 32060859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of expanding a paediatric OPAT programme with an antimicrobial stewardship intervention.
    Huynh J; Hodgson KA; Boyce S; Ibrahim LF; Bryant PA
    Arch Dis Child; 2020 Dec; 105(12):1220-1228. PubMed ID: 32381516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.